DE122007000005I2 - Apolipoprotein-b syntheseinhibitoren - Google Patents
Apolipoprotein-b syntheseinhibitorenInfo
- Publication number
- DE122007000005I2 DE122007000005I2 DE122007000005C DE122007000005C DE122007000005I2 DE 122007000005 I2 DE122007000005 I2 DE 122007000005I2 DE 122007000005 C DE122007000005 C DE 122007000005C DE 122007000005 C DE122007000005 C DE 122007000005C DE 122007000005 I2 DE122007000005 I2 DE 122007000005I2
- Authority
- DE
- Germany
- Prior art keywords
- hibitors
- apolipoprotein
- synthesis
- synthesis hibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203120 | 1994-10-27 | ||
| US08/455,304 US5521186A (en) | 1994-10-27 | 1995-05-31 | Apolipoprotein-β synthesis inhibitors |
| PCT/EP1995/004111 WO1996013499A1 (en) | 1994-10-27 | 1995-10-19 | Apolipoprotein-b synthesis inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE122007000005I2 true DE122007000005I2 (de) | 2008-04-24 |
Family
ID=26136684
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1995619995 Pending DE122007000005I1 (de) | 1994-10-27 | 1995-10-19 | Apolipoprotein-B Syntheseinhibitoren |
| DE122007000005C Active DE122007000005I2 (de) | 1994-10-27 | 1995-10-19 | Apolipoprotein-b syntheseinhibitoren |
| DE69519995T Expired - Lifetime DE69519995T2 (de) | 1994-10-27 | 1995-10-19 | Apolipoprotein-b syntheseinhibitoren |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1995619995 Pending DE122007000005I1 (de) | 1994-10-27 | 1995-10-19 | Apolipoprotein-B Syntheseinhibitoren |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69519995T Expired - Lifetime DE69519995T2 (de) | 1994-10-27 | 1995-10-19 | Apolipoprotein-b syntheseinhibitoren |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5929075A (de) |
| EP (1) | EP0788496B1 (de) |
| JP (1) | JP3025907B2 (de) |
| KR (1) | KR100227231B1 (de) |
| CN (1) | CN1068000C (de) |
| AP (1) | AP779A (de) |
| AT (1) | ATE198889T1 (de) |
| AU (1) | AU697744C (de) |
| BG (1) | BG63694B1 (de) |
| BR (1) | BR9509436A (de) |
| CA (1) | CA2203274C (de) |
| CY (1) | CY2256B1 (de) |
| CZ (1) | CZ286476B6 (de) |
| DE (3) | DE122007000005I1 (de) |
| DK (1) | DK0788496T3 (de) |
| ES (1) | ES2155535T3 (de) |
| FI (1) | FI119548B (de) |
| GR (1) | GR3035519T3 (de) |
| HR (1) | HRP950532B1 (de) |
| HU (1) | HU219862B (de) |
| IL (1) | IL115771A (de) |
| LU (1) | LU91306I2 (de) |
| NO (1) | NO311937B1 (de) |
| NZ (1) | NZ295353A (de) |
| OA (1) | OA10479A (de) |
| PT (1) | PT788496E (de) |
| RO (1) | RO118715B1 (de) |
| SK (1) | SK281908B6 (de) |
| TR (1) | TR199501295A2 (de) |
| WO (1) | WO1996013499A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1028730B1 (de) * | 1997-11-03 | 2002-04-17 | Janssen Pharmaceutica N.V. | Arzneimittel enthaltend lipidsenkende verbindungen |
| SK15252000A3 (sk) * | 1998-04-27 | 2001-10-08 | Janssen Pharmaceutica N. V. | Peleta, ktorej jadro je obalené činidlom znižujúcim lipidy a polymérom |
| US6451802B1 (en) * | 1998-12-22 | 2002-09-17 | Janssen Pharmaceutica N.V. | S-oxide lipid lowering compounds |
| DE19945982A1 (de) * | 1999-09-24 | 2001-03-29 | Knoll Ag | Geschwindigkeitsbestimmte Partikel |
| US20050132022A1 (en) * | 2003-12-12 | 2005-06-16 | International Business Machines Corporation | Computer system with LAN-based I/O |
| EP1708680A2 (de) * | 2004-01-21 | 2006-10-11 | Janssen Pharmaceutica N.V. | Orale mitratapidlösung |
| US7649002B2 (en) | 2004-02-04 | 2010-01-19 | Pfizer Inc | (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
| WO2005097131A2 (en) * | 2004-04-09 | 2005-10-20 | Janssen Pharmaceutica N.V. | Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors |
| US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| CA2609783A1 (en) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| US20080269233A1 (en) * | 2005-08-04 | 2008-10-30 | Mark David Andrews | Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| RS20080371A (en) * | 2006-02-23 | 2009-07-15 | Pfizer Limited, | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| WO2008059335A1 (en) | 2006-11-13 | 2008-05-22 | Pfizer Products Inc. | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| ATE474836T1 (de) * | 2007-05-25 | 2010-08-15 | Janssen Pharmaceutica Nv | Verbesserte synthese von (2s-cis)-2-(brommethyl)- 2-(4-chlorphenyl)-1,3-dioxolan-4-methanol- methansulfonat(ester) |
| MX2011001405A (es) * | 2008-08-06 | 2011-03-21 | Pfizer Ltd | Compuestos de diazepina y diazocano como agonistas de mc4. |
| EP2571871B1 (de) * | 2010-05-19 | 2017-06-21 | Sandoz AG | Verfahren zur Herstellung von chiralen Triazolonen |
| IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4313953A (en) * | 1978-06-23 | 1982-02-02 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4766125A (en) * | 1981-06-23 | 1988-08-23 | Janssen Pharmaceutica N.V. | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia |
| US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
-
1995
- 1995-10-19 RO RO97-00812A patent/RO118715B1/ro unknown
- 1995-10-19 WO PCT/EP1995/004111 patent/WO1996013499A1/en active IP Right Grant
- 1995-10-19 AT AT95937804T patent/ATE198889T1/de active
- 1995-10-19 PT PT95937804T patent/PT788496E/pt unknown
- 1995-10-19 DK DK95937804T patent/DK0788496T3/da active
- 1995-10-19 BR BR9509436A patent/BR9509436A/pt not_active IP Right Cessation
- 1995-10-19 KR KR1019970702662A patent/KR100227231B1/ko not_active IP Right Cessation
- 1995-10-19 DE DE1995619995 patent/DE122007000005I1/de active Pending
- 1995-10-19 EP EP95937804A patent/EP0788496B1/de not_active Expired - Lifetime
- 1995-10-19 HU HU9701956A patent/HU219862B/hu not_active IP Right Cessation
- 1995-10-19 ES ES95937804T patent/ES2155535T3/es not_active Expired - Lifetime
- 1995-10-19 CA CA002203274A patent/CA2203274C/en not_active Expired - Fee Related
- 1995-10-19 AU AU38680/95A patent/AU697744C/en not_active Ceased
- 1995-10-19 CZ CZ19971198A patent/CZ286476B6/cs not_active IP Right Cessation
- 1995-10-19 NZ NZ295353A patent/NZ295353A/en not_active IP Right Cessation
- 1995-10-19 DE DE122007000005C patent/DE122007000005I2/de active Active
- 1995-10-19 CN CN95195885A patent/CN1068000C/zh not_active Expired - Fee Related
- 1995-10-19 US US08/817,247 patent/US5929075A/en not_active Expired - Lifetime
- 1995-10-19 SK SK507-97A patent/SK281908B6/sk not_active IP Right Cessation
- 1995-10-19 JP JP8514288A patent/JP3025907B2/ja not_active Expired - Fee Related
- 1995-10-19 DE DE69519995T patent/DE69519995T2/de not_active Expired - Lifetime
- 1995-10-19 AP APAP/P/1997/000968A patent/AP779A/en active
- 1995-10-20 TR TR95/01295A patent/TR199501295A2/xx unknown
- 1995-10-26 IL IL11577195A patent/IL115771A/xx not_active IP Right Cessation
- 1995-10-27 HR HR950532A patent/HRP950532B1/xx not_active IP Right Cessation
-
1997
- 1997-04-10 BG BG101402A patent/BG63694B1/bg unknown
- 1997-04-24 NO NO19971895A patent/NO311937B1/no not_active IP Right Cessation
- 1997-04-25 FI FI971784A patent/FI119548B/fi not_active IP Right Cessation
- 1997-04-25 OA OA60997A patent/OA10479A/en unknown
-
2001
- 2001-03-05 GR GR20010400359T patent/GR3035519T3/el unknown
-
2002
- 2002-01-04 CY CY0200004A patent/CY2256B1/xx unknown
-
2007
- 2007-01-17 LU LU91306C patent/LU91306I2/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122007000005I2 (de) | Apolipoprotein-b syntheseinhibitoren | |
| FI972970A (fi) | Uusia yhdisteitä | |
| DK0777671T3 (da) | Spiro-azabicykliske forbindelser | |
| FI955927A0 (fi) | Substituoidut 1H-imidatsolit | |
| BR9509760A (pt) | Composto | |
| FI20030370A (fi) | Uusia yhdisteitä | |
| DE69534718D1 (de) | Substituierte 9-alkyladenine | |
| ZA959084B (en) | Apolipoprotein-b synthesis inhibitors | |
| DE69630414D1 (de) | 5B4T-Kodierungsschema | |
| FI970151A0 (fi) | Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä | |
| BR9509740A (pt) | Compostos 18-nor-vitamina d | |
| BR9509559A (pt) | Azolilulsolfonilfeniluracilas substituídas | |
| DE59510274D1 (de) | Substituierte biphenyloxazoline | |
| CY2007006I1 (el) | Αναστολεις συνθεσης απολιποπρωτεινης-β | |
| SE9404416D0 (sv) | Novel compounds | |
| FI1878U1 (fi) | Maskmetspoe utan floete | |
| FI943697A0 (fi) | Riktningventil utan roera delar | |
| ITMI942305A0 (it) | Ciclo-pentapeptidi antanonisti di tachichinine | |
| FI922261A (fi) | Saekerhetssystem foer fordon utan foerarhytt | |
| SE9502559D0 (sv) | Novel compounds | |
| SE9503561D0 (sv) | New Compounds | |
| SE9403034D0 (sv) | SIBAB-säkring | |
| SE9402838D0 (sv) | New compounds | |
| SE9403728D0 (sv) | New compounds | |
| SE9402813D0 (sv) | New compounds |